DBV Technologies Falls 45% Following Failed Peanut Allergy Trial

By: via Benzinga
DBV Technologies SA - ADR (NASDAQ: DBVT) shares are trading lower by $22.00 (46 percent) at $26.07 in Monday's session. Before the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.